Clinical Research Directory
Browse clinical research sites, groups, and studies.
Isavuconazole in Critically Ill Patients: Efficacy and Safety
Sponsor: Shanghai 10th People's Hospital
Summary
Due to factors such as disease status, gastrointestinal conditions, commonly used medications (e.g., vasopressors), and cardiac output, the plasma concentration of isavuconazole in critically ill patients may differ from that in healthy individuals, exhibiting significant variability. This study aims to explore the variability of isavuconazole plasma concentrations in critically ill patients and its correlation with efficacy and adverse effects. The research includes: 1. The distribution and variability of isavuconazole plasma concentrations in critically ill patients; 2. Clinical outcomes; 3. Adverse effects.
Official title: Isavuconazole in Critically Ill Patients: A Study on Antifungal Efficacy and Safety
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
75
Start Date
2025-08-01
Completion Date
2030-12-31
Last Updated
2025-07-23
Healthy Volunteers
No
Interventions
Isavuconazole treatment
Administer isavuconazole as follows: Loading dose: 200 mg every 8 hours (q8h) for three times, Maintenance dose: 200 mg once daily (qd)